Ionctura
Clinical trials sponsored by Ionctura, explained in plain language.
-
New drug aims to boost immune system against advanced cancers
Disease control OngoingThis early-stage study tests a new drug called IOA-244 in about 210 adults with advanced or metastatic cancers like lung cancer, melanoma, and lymphoma. The main goal is to see if the drug is safe and tolerable, both alone and combined with other treatments. Researchers also chec…
Phase: PHASE1 • Sponsor: iOnctura • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill shows promise in Hard-to-Treat eye cancer
Disease control OngoingThis phase 2 trial tests a new drug called roginolisib against standard treatments in 85 adults with advanced uveal melanoma, a rare eye cancer. The study aims to see if roginolisib helps people live longer and improves their quality of life. Participants are randomly assigned to…
Phase: PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for lung cancer patients Who've tried everything?
Disease control OngoingThis trial tests a new drug called roginolisib combined with two other drugs (dostarlimab and docetaxel) in 45 adults with advanced non-squamous lung cancer that has worsened after standard treatments. The main goals are to see if the combo is safe and whether it reduces certain …
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC